Table 4.
Author, Year | Was True Randomization Used for Assignment of Participants to Treatment Groups? | Was Allocation to Treatment Groups Concealed? | Were Treatment Groups Similar at the Baseline? | Were Participants Blind to Treatment Assignment? | Were Those Delivering Treatment Blind to Treatment Assignment? | Were Outcomes Assessors Blind to Treatment Assignment? | Were Treatment Groups Treated Identically Other Than the Intervention of Interest? | Was Follow up Complete and if not, Were Differences between Groups in Terms of Their Follow up Adequately Described and Analyzed? | Were Participants Analyzed in the Groups to Which They Were Randomized? | Were Outcomes Measured in the Same Way for Treatment Groups? | Were Outcomes Measured in a Reliable Way? | Was Appropriate Statistical Analysis Used? | Was the Trial Design Appropriate, and Any Deviations from the Standard RCT Design (Individual Randomization, Parallel Groups) Accounted for in the Conduct and Analysis of the Trial? | Johanna Briggs Institute Score |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Argut, S.K. 2021 [66] | ✓ | ✓ | ✓ | ✓ | ✓ | X | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | 12 |
Cruz-Montecinos, C. 2016 [67] | ✓ | ✓ | X | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | 12 |
Goślińska, J. 2020 [68] | ✓ | ✓ | X | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | 12 |
Telles, G. 2016 [69] | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | 13 |
✓—Yes, X—No.